Industry News
Ovarian Cancer Study Proves Drug Delays Disease Progression, May Improve Survival
Dec 29, 2011
Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, University Health Network and Timothy Perren, St James's Institute of Oncology, Leeds, UK... Read More
Ovarian Cancer Study Proves Drug Delays Disease Progression, May Improve Survival
Dec 29, 2011
Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, University Health Network and Timothy Perren, St James's Institute of Oncology, Leeds, UK... Read More
Key Genetic Error Found In Family Of Blood Cancers
Dec 29, 2011
Scientists have uncovered a critical genetic mutation in some patients with myelodysplastic syndromes - a group of blood cancers that can progress to a fatal form of leukemia. The research team at Washington University School of Medicine in St. Louis also found evidence that patients with the mutation are more likely to develop acute leukemia... Read More
Targeted Blocking Of Cell Death Prevents Fatal Condition Septic Shock
Dec 29, 2011
Researchers of VIB and UGent have discovered a new approach to preventing septic shock, an often fatal extreme inflammatory reaction of the body. It is the most frequent cause of death at intensive care departments in hospitals. In sepsis, acute inflammation is attended by low blood pressure and blood clots, causing the organs to stop working... Read More
Futuristic Therapy: Steering Microrobots Through Blood Vessels For Disease Treatment
Dec 29, 2011
Microscopic-scale medical robots represent a promising new type of therapeutic technology. As envisioned, the microbots, which are less than one millimeter in size, might someday be able to travel throughout the human bloodstream to deliver drugs to specific targets or seek out and destroy tumors, blood clots, and infections that can't be easily accessed in other ways... Read More
State Will Pay For PIP Breast Implant Removal, Says Venezuelan Health Minister
Dec 28, 2011
Venezuelan Health Minister, Eugenia Sader, has announced that the full costs of removing the Poly Implant Prothèses (PIP) breast implants will be covered by the state. Ms. Sader emphasized that this offer stands for any woman who wishes to have them removed. French authorities have also offered to cover the full costs... Read More
Promising Treatments For Blood Cancers Presented By JT Cancer Center Researchers At ASH Meeting
Dec 28, 2011
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 best hospitals for cancer, presented results from 31 major studies of blood-related cancers - leukemia, lymphoma and multiple myeloma -- during the American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011 in San Diego... Read More
Hide And Seek Signals In The Immune System
Dec 28, 2011
The white blood cells that fight disease and help our bodies heal are directed to sites of infection or injury by 'exit signs' - chemical signals that tell them where to pass through the blood vessel walls and into the underlying tissue... Read More
ORNL Image Analysis Prowess Advances Retina Research
Dec 27, 2011
Armed with a new ability to find retinal anomalies at the cellular level, neurobiologists at St. Jude Children's Research Hospital have made a discovery they hope will ultimately lead to a treatment for cancer of the retina. While much work remains, Oak Ridge National Laboratory's specialized tracing algorithm allows researchers to analyze thousands of cells instead of just a few dozen... Read More
Bevacizumab Reduces Nasopharyngeal Carcinoma Spread - Trial Finds
Dec 27, 2011
According to a new phase 2 trial published Online First in The Lancet Oncology, the combination of the widely used anti-cancer drug bevacizumab with standard chemo-radiation therapy is safe, and could prolong survival in patients with advanced nasopharyngeal carcinoma, without any apparent increased adverse side effects... Read More
Previous Page Next Page